A Second-Generation Nanoluc-IL27 Fusion Cytokine for Targeted-Gene-Therapy Applications

An emerging approach in treating skeletal malignancies utilizes osteoimmunology to investigate new multifunctional immune-stimulatory agents that can simultaneously combat tumor growth and promote bone repair. We have hypothesized that cytokine Interleukin-27 (IL-27) is an excellent candidate biolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Salameh, Janelle Wesleyn, Kumar, Shreya, Rivera-Cruz, Cosette Marie, Figueiredo, Marxa Leao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868604/
https://www.ncbi.nlm.nih.gov/pubmed/35200430
http://dx.doi.org/10.3390/bioengineering9020077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868604/
https://www.ncbi.nlm.nih.gov/pubmed/35200430
http://dx.doi.org/10.3390/bioengineering9020077

Ejemplares similares